NewsBur
No Result
View All Result
Friday, January 22, 2021
  • Home
  • Morning News
  • Market News
  • Analyst Actions
  • Trending Stocks
Subscribe
Newsbur
  • Home
  • Morning News
  • Market News
  • Analyst Actions
  • Trending Stocks
No Result
View All Result
Newsbur
No Result
View All Result
Home Analyst Actions

CareDx Inc (CDNA)’s recent price decline sees it further from the 1-year target. Can it reach the target soon?

by Justin Shaw
June 30, 2020
in Analyst Actions
0
0
SHARES
15
VIEWS
Share on FacebookShare on Twitter

CareDx Inc (NASDAQ:CDNA) went up by 8.35% during the previous trading session, and it is maintaining the win ahead of Monday’s trading session. The share price of the Diagnostics & Research giant went up by $34.14 to trade ended Monday trading at $31.51. This is up from the $31.51 price recorded on Friday’s trading session. Thanks to this latest performance, CDNA is closer to the higher price 52-week target of $54.00 and further from the lowest price target of $35.00. Its performance from the start of the year has also been positive, with CDNA up by 58.28% year-to-date.

CareDx Inc (CDNA) started the day trading at $31.85 and recorded an intraday high of $34.44. It also recorded an intraday low of $31.6 during Monday’s trading session. CareDx Inc is a very active stock that recorded a trading volume that is less than -7.64% of the average daily trading volume on Monday. The stock’s trading volume on Monday was 621298, which is less than -7.64 of the total average daily trading volume of 668.74K.

CareDx Inc (NASDAQ:CDNA) 2020 Performance Impressive

The increase in CDNA’s stock price on Monday saw its overall performance boost over the past few months. We can quantify the performance of the stock so far this year using a few metrics. The 52-week high price of CDNA currently stands at $41.27, which is higher than the current trading price of the stock by 17.28%. However, CDNA’s current trading price is -161.81% lower than the 52-week low price of $13.04. In terms of trading volume, CareDx Inc currently experienced healthy participation during the last trading session. 621298 shares of CareDx Inc were traded on the stock exchange on Monday, which is less than -7.64% of the 668.74K average trading volume of the stock.

The performance of the stock has been positive over the past year. CDNA’s performance over the past one year has seen it plunge by -5.14%, while the stock has gone up by 59.16% in the last six months. The quarterly performance of CDNA currently stands at 52.41%, and it is up by 6.29% in the last month. The only positive figure was from the weekly performance, which currently reads 1.19%. At the time of writing CDNA’s report, the company has a total market cap of $1.69B, making it one of the largest publicly-traded companies in the world.CareDx Inc also has over 306 employees all over the world.

CDNA Insider Activities

For CareDx Inc, insiders hold 93.50% of all company shares. The insider transactions over the past six months are up by 11.70%. During that period, insiders bought 287,237 shares in 34 transactions. In that same period, insiders sold 317,051 of their shares in 27 transactions. After these transactions, insiders at CareDx Inc now hold 1.09M shares, which is over 97.01% of the total company stocks. Institutional investors currently hold a large chunk of the CDNA shares, as they control 2.49% of the company’s total stock.

CDNA Fundamental Analysis

For CareDx Inc, the stock’s diluted earnings per share (EPS) stands at -0.48. In the coming year, analysts expect the EPS to be 0.57. The EPS growth will up over the next five years to 20.00% after plunging by -52.30% in the previous five years. In terms of revenue, CareDx Inc’s quarterly sales (YOY) is shrinking at -0.04, which is higher than the average annual revenue of -52.30% over the past half a decade.

The Return on Investment (ROI) on CareDx Inc’s stock currently stands at -22.80%, and it has a net profit margin of -14.50%. The operating margin of the company is -17.80%, and its gross margin is 65.50%.

CDNA Analysts Prediction

The H.C. Wainwright also has a Buy rating for CareDx Inc, predicting the stock price to stay between $40 and $37. H.C. Wainwright reiterate their Buy position on the stock ($30 and $43)

Jefferies and H.C. Wainwright also believe that CareDx Inc’s stock is outperforming at the moment. CDNA received a positive rating from H.C. Wainwright, which set a price target of $17-$22 for the stock.

CDNA Technical Analysis

The Simple Moving Average (SMA) is one of the most powerful technical indicators. The 20-day Simple Moving Average of CDNA currently stands at 4.91%, while the SMA50 is 14.50%. The biggest one is the SMA200, which is currently reading 39.96% ahead of Monday’s trading session. The Relative Strength Index of this stock is 58.87.

Tags: CareDx IncCDNACDNA stockNASDAQ:CDNA

Recommended Stories

After-Hours Trading Alert: AT&T Inc. [T] is Up 0.48% After the Bell

September 11, 2020

Ra Medical Systems Inc. [RMED]’s Market Cap is $17.98 million and Here is Where it Goes Next

September 11, 2020

Premier Inc. (PINC) Down by -0.13% in latest market performance. Is it leading the Healthcare sector?

July 8, 2020

Popular Stories

  • Sorrento Therapeutics Inc. [SRNE] is One of the Best Plays in Healthcare and This Proves It

    0 shares
    Share 0 Tweet 0
  • Heat Biologics Inc. [HTBX] is One of the Best Plays in Healthcare and This Proves It

    0 shares
    Share 0 Tweet 0
  • Heat Biologics Inc. [HTBX] Is Skyrocketing 13.15% on Pure Fundamentals

    0 shares
    Share 0 Tweet 0
  • BlackBerry Limited [BB] is a Top Ten Buy with Quarterly Revenues of 999.00M

    0 shares
    Share 0 Tweet 0
  • Impressive Profit Margins of -5.80% Raise Bull Flags for General Electric Company [GE]

    0 shares
    Share 0 Tweet 0

NewsBur.com

Newsbur.com is an Economic news website, which offers broad information about the Stock markets and Equities. The major emphasis of this platform is to present, the most practical recommendation for public and private capital sharing, both in the form of updates and detailed analysis.

Recent Posts

  • After-Hours Trading Alert: Amgen Inc. [AMGN] is Up 0.85% After the Bell
  • Has Dynatrace Inc. [DT] Completely Outpaced Other Companies in the Technology This Year?
  • Why Applied Materials Inc. [AMAT]’s 1.55% Drop is No Cause for Alarm

Categories

  • Analyst Actions
  • Market News
  • Morning News
  • Trending Stocks
  • Uncategorized

© 2020 Copyright © All Rights Reserved.

No Result
View All Result
  • Home
  • Market News
  • Morning News
  • Analyst Actions
  • Trending Stocks

© 2020 Copyright © All Rights Reserved.